A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis

7Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Adiponectin receptors, AdipoR1 and AdipoR2 are promising targets for the prevention and treatment of metabolic diseases. In this study, we aimed to establish agonistic antibodies against AdipoR1 and AdipoR2 with a long enough half-life to provide a means of improving poor medication adherence associated with preclinical small-molecule AdipoR agonists or existing antidiabetic drugs. Monoclonal antibodies were obtained by immunizing AdipoR knockout mice with human AdipoR-expressing cells. Of the antibodies shown to bind to both, an agonist antibody was obtained, which exhibited adenosine 50-monophosphate–activated protein kinase–activating properties such as adiponectin and was named AdipoR-activating monoclonal antibody (AdipoRaMab). AdipoRaMab ameliorated glucose intolerance in high-fat diet–fed mice, which was not observed in AdipoR1·AdipoR2 double knockout mice. AdipoRaMab exhibited anti-inflammatory and antifibrotic effects in the nonalcoholic steatohepatitis (NASH) model, indicating its therapeutic potential in diabetes and in NASH. In addition, the results of this study indicated that AdipoRaMab may exert therapeutic effects even in a once-monthly dosing regimen through its humanization.

References Powered by Scopus

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

8808Citations
N/AReaders
Get full text

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

4287Citations
N/AReaders
Get full text

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

3653Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Adipokines: masterminds of metabolic inflammation

8Citations
N/AReaders
Get full text

Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis

2Citations
N/AReaders
Get full text

Exploring mechanisms of insulin action and strategies to treat diabetes

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Asahara, N., Okada-Iwabu, M., Iwabu, M., Wada, K., Oka, K., Yamauchi, T., & Kadowaki, T. (2023). A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis. Science Advances, 9(45). https://doi.org/10.1126/sciadv.adg4216

Readers over time

‘23‘24‘2506121824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

43%

Researcher 3

43%

Professor / Associate Prof. 1

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

33%

Pharmacology, Toxicology and Pharmaceut... 2

33%

Energy 1

17%

Biochemistry, Genetics and Molecular Bi... 1

17%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0